A PROGRESS REPORT ON THE DEVELOPMENT OF VITAMIN A DERIVATIVES Newsletter Article 14 February 2013 Pages: 2 - 3
INTRACORONARY STREPTOKINASE FOR ACUTE CORONARY ARTERY THROMBOSIS Newsletter Article 14 February 2013 Pages: 3 - 4
THE CANCER AND STEROID HORMONE STUDY: A PRELIMINARY REPORT Newsletter Article 14 February 2013 Pages: 5 - 6
BUPROPION: as effective as imipramine in depressed patients Newsletter Article 14 February 2013 Pages: 6 - 6
KATACALCIN: a newly identified calciumregulating hormone Newsletter Article 14 February 2013 Pages: 6 - 7
ALTERNATIVES TO ANTIBIOTICS IN TREATING PERSISTENT ACNE VULGARIS Newsletter Article 14 February 2013 Pages: 7 - 8
MEPTAZINOL BENEFITS PATIENTS WITH LOUSE-BORNE RELAPSING FEVER Newsletter Article 14 February 2013 Pages: 8 - 9
FOOD/DRUG ALLERGIES MAY BE PREVENTED BY SODIUM CROMOGLYCATE Newsletter Article 14 February 2013 Pages: 9 - 9
THE WHEEZE AND WHEREFORES IN TREATING PAEDIATRIC ASTHMA Newsletter Article 14 February 2013 Pages: 10 - 10
MAINTENANCE PROPRANOLOL SEEMS TO BENEFIT MI SURVIVORS Newsletter Article 14 February 2013 Pages: 11 - 11
SODIUM VALPROATE ACCUMULATES IN INFANTS OF EPILEPTIC MOTHERS Newsletter Article 14 February 2013 Pages: 13 - 13
COMPARING THE ACTION AND AVAILABILITY OF DIFFERENT DRUG FORMULATIONS Newsletter Article 14 February 2013 Pages: 13 - 14
ACTIVE METHYLDOPA METABOLITES MAY ACCUMULATE IN RENAL FAILURE Newsletter Article 14 February 2013 Pages: 14 - 14
LIPOPROTEIN LEVELS ARE AFFECTED BY OCs AND EXOGENOUS OESTROGENS Newsletter Article 14 February 2013 Pages: 14 - 15
LIPOPHILIC β-BLOCKERS APPEAR TO INTERFERE WITH SLEEP Newsletter Article 14 February 2013 Pages: 15 - 15
THE PROS AND CONS OF OESTROGEN REPLACEMENT THERAPY Newsletter Article 14 February 2013 Pages: 15 - 17
THE DEVELOPMENT AND PROPERTIES OF AN INDOMETHACIN OSMOTIC SYSTEM Newsletter Article 14 February 2013 Pages: 17 - 18
ASTEMIZOLE: long acting antihistamine without effect on the CNS. Marketed in the UK by Janssen - a world first introduction Newsletter Article 14 February 2013 Pages: 19 - 19
CYCLOSPORIN A (OL-27-400): antilymphocytic immunosuppressive marketed this year in Switzerland and the UK by Sandoz for prevention of transplant rejection Newsletter Article 14 February 2013 Pages: 19 - 20